Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
The Top Jobs to Look For in 2023
Scott Dobroski, career trend expert at Indeed, joined Cheddar News to discuss job trends in 2023 as the U.S. labor market remains robust despite some high-profile layoffs.
Load More